Status:
WITHDRAWN
Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
Lead Sponsor:
University of Nebraska
Conditions:
Wounds
Infection
Eligibility:
All Genders
19-90 years
Phase:
NA
Brief Summary
This study will determine if autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease infection in coronary artery bypass grafting surgery patients.
Detailed Description
The purpose of this study is to determine if the use of autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease the incidence of infection in patien...
Eligibility Criteria
Inclusion
- Any patient who meets criteria and consents to undergo a CABG procedure involving conduit sites and consents to this study.
Exclusion
- Any patient, after inclusion, whom is later determined to have had on-going therapy that could influence wound healing such as radiation or chemotherapy, extensive steroid use, or accidental trauma such as burns, etc.
Key Trial Info
Start Date :
January 13 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 6 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00672672
Start Date
January 13 2009
End Date
January 6 2010
Last Update
August 15 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.